#WeTheWomen: Invest in Education and Empower Women and Girls to Lead
International Women's Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW...
CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy
Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional market...
Geotab Safety Center supports next-generation solutions leveraging AI and predictive collision insights
Geotab Safety Center offers enhanced visibility into fleet risk SINGAPORE, Feb. 21, 2024 /PRNewswir...
Geotab Safety Center supports next-generation solutions leveraging AI and predictive collision insights
Geotab Safety Center offers enhanced visibility into fleet risk SYDNEY, Feb. 21, 2024 /PRNewswire/ ...
2024 Global Appeal Calls for Well-Informed Public to 'Break Chains of Discrimination' against Leprosy
TOKYO, Feb. 1, 2024 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative has partnered wi...
Learning for a Lasting Peace: International Day of Education Statement by Education Cannot Wait Executive Director Yasmine Sherif
NEW YORK, Jan. 24, 2024 /PRNewswire/ -- Education is the bedrock of peace, the foundation of strong...
Kemin Industries Introduces New Global Tagline: Compelled by Curiosity™
New tagline reflects driving force behind company's vision to transform lives and the unifying qual...
Chengdu Hi-tech Zone Jiaozi Avenue Metaverse District Opens on the 1st Day of the New Year
CHENGDU, China, Jan. 3, 2024 /PRNewswire/ -- On the evening of January 1st, amid the footfalls of t...
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces th...
Freedom, Equality and Justice Lead to Peace
Human Rights Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW YORK, D...
Denmark Announces Groundbreaking US$6.5 Million Contribution to Education Cannot Wait to Scale-Up Education Response to the Climate Crisis
ECW is calling on world leaders to urgently provide US$150 million in additional funding to expand ...
The International Chamber of Commerce - Hong Kong Celebrates 25 Years of Services Elevating Hong Kong's International Reputation
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- The International Chamber of Commerce – Hong Kong (ICC-HK) ...
BMO Financial Group Reports Fourth Quarter and Fiscal 2023 Results
BMO's 2023 audited annual consolidated financial statements and accompanying Management Discussion ...
End Violence Against Women
International Day for the Elimination of Violence Against Women Statement by Education Cannot Wait ...
The Full Force of Tolerance
International Day of Tolerance Statement by Education Cannot Wait Executive DirectorYasmine Sherif ...
Global Times: Xizang in the New Era: Why are boarding schools embraced by residents in Xizang?
BEIJING, Nov. 13, 2023 /PRNewswire/ -- Majestic snow-capped mountains, vast grasslands, and deep go...
Maxeon Solar Technologies Wins Apex Award for "Sustainable Business" at United Nations Global Compact Network Singapore's Award Ceremony
SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), a global lea...
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent"...
Accelex Announces $15M Series A Funding Round Led by FactSet; Firms Set to Automate Critical Private Markets Workflows for Investors
LONDON, Nov. 2, 2023 /PRNewswire/ -- Accelex, a leading provider of AI automation for private marke...
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
* FDA granted Breakthrough Therapy Designation for felzartamab in PMN upon positive clinical data...